A comprehensive review on the role of the gut microbiome in human neurological disorders

SG Sorboni, HS Moghaddam… - Clinical microbiology …, 2022 - journals.asm.org
The human body is full of an extensive number of commensal microbes, consisting of
bacteria, viruses, and fungi, collectively termed the human microbiome. The initial …

APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer's disease pathology and brain diseases

R Fernández-Calle, SC Konings… - Molecular …, 2022 - Springer
ApoE is the major lipid and cholesterol carrier in the CNS. There are three major human
polymorphisms, apoE2, apoE3, and apoE4, and the genetic expression of APOE4 is one of …

Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies

Y Yamazaki, N Zhao, TR Caulfield, CC Liu… - Nature Reviews …, 2019 - nature.com
Polymorphism in the apolipoprotein E (APOE) gene is a major genetic risk determinant of
late-onset Alzheimer disease (AD), with the APOE* ε 4 allele conferring an increased risk …

Multifaceted roles of APOE in Alzheimer disease

RJ Jackson, BT Hyman, A Serrano-Pozo - Nature Reviews Neurology, 2024 - nature.com
For the past three decades, apolipoprotein E (APOE) has been known as the single greatest
genetic modulator of sporadic Alzheimer disease (AD) risk, influencing both the average age …

Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight

Y Shi, DM Holtzman - Nature Reviews Immunology, 2018 - nature.com
Alzheimer disease is more than a pure proteopathy. Chronic neuroinflammation stands out
during the pathogenesis of the disease and in turn modulates disease progression. The …

A quarter century of APOE and Alzheimer's disease: progress to date and the path forward

ME Belloy, V Napolioni, MD Greicius - Neuron, 2019 - cell.com
Alzheimer's disease (AD) is considered a polygenic disorder. This view is clouded, however,
by lingering uncertainty over how to treat the quasi" monogenic" role of apolipoprotein E …

APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therapeutic approaches

A Serrano-Pozo, S Das, BT Hyman - The Lancet Neurology, 2021 - thelancet.com
The APOE ε4 allele remains the strongest genetic risk factor for sporadic Alzheimer's
disease and the APOE ε2 allele the strongest genetic protective factor after multiple large …

Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture

R Chia, MS Sabir, S Bandres-Ciga, S Saez-Atienzar… - Nature …, 2021 - nature.com
The genetic basis of Lewy body dementia (LBD) is not well understood. Here, we performed
whole-genome sequencing in large cohorts of LBD cases and neurologically healthy …

ApoE4: an emerging therapeutic target for Alzheimer's disease

M Safieh, AD Korczyn, DM Michaelson - BMC medicine, 2019 - Springer
Background The growing body of evidence indicating the heterogeneity of Alzheimer's
disease (AD), coupled with disappointing clinical studies directed at a fit-for-all therapy …

APOE2: protective mechanism and therapeutic implications for Alzheimer's disease

Z Li, F Shue, N Zhao, M Shinohara, G Bu - Molecular neurodegeneration, 2020 - Springer
Investigations of apolipoprotein E (APOE) gene, the major genetic risk modifier for
Alzheimer's disease (AD), have yielded significant insights into the pathogenic mechanism …